52 related articles for article (PubMed ID: 2002856)
1. [Zidovudine treatment and need of blood transfusion in patients with AIDS].
Ligtenberg PC; Hoepelman IM; Vrehen HM; Borleffs JC
Ned Tijdschr Geneeskd; 1991 Jan; 135(4):130-3. PubMed ID: 2002856
[TBL] [Abstract][Full Text] [Related]
2. [Zidovudine therapy in 141 patients with symptoms of HIV infection; a multicenter study].
Perenboom R; Reiss P; Danner SA; van 't Wout JW
Ned Tijdschr Geneeskd; 1990 Jan; 134(3):120-4. PubMed ID: 2405287
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study.
Stambuk D; Youle M; Hawkins D; Farthing C; Shanson D; Farmer R; Lawrence A; Gazzard B
Q J Med; 1989 Feb; 70(262):161-74. PubMed ID: 2512592
[TBL] [Abstract][Full Text] [Related]
5. Zidovudine (AZT) for treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice.
Colson ER; Horwitz RI; Bia FJ; Viscoli CM
Arch Intern Med; 1991 Apr; 151(4):709-13. PubMed ID: 2012453
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of AIDS patients with zidovudine].
Buijs L; Pietersz RN; van den Berg-Wolf MG; Reesink HW; ten Veen JH
Ned Tijdschr Geneeskd; 1990 Jan; 134(2):71-5. PubMed ID: 2296325
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of treatment with AZT of patients with AIDS and symptomatic HIV infection.
Cox PH; Martin MA; Styer CM; Beall GN
Nurse Pract; 1990 May; 15(5):36, 39-44. PubMed ID: 2342666
[TBL] [Abstract][Full Text] [Related]
8. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
[TBL] [Abstract][Full Text] [Related]
9. Transfusion associated AIDS in Mexico. Clinical spectrum, conditional latency distribution, and survival.
Volkow P; Ponce de León S; Calva J; Ruiz-Palacios G; Mohar A
Rev Invest Clin; 1993; 45(2):133-8. PubMed ID: 8337540
[TBL] [Abstract][Full Text] [Related]
10. [Clinical experience with zidovudine in patients with acquired immunodeficiency syndrome. Analysis of 117 cases. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas].
Biedma D; Bascuñana A; Viciana P; Causse M; Torres Tortosa M; Lozano de León F; Pujol E; Pachón J
Rev Clin Esp; 1992 Sep; 191(4):187-92. PubMed ID: 1439038
[TBL] [Abstract][Full Text] [Related]
11. Implications of generalists' slow adoption of zidovudine in clinical practice.
Markson LE; Cosler LE; Turner BJ
Arch Intern Med; 1994 Jul; 154(13):1497-504. PubMed ID: 8018005
[TBL] [Abstract][Full Text] [Related]
12. Zidovudine (Retrovir) update.
Rachlis AR
CMAJ; 1990 Dec; 143(11):1177-85. PubMed ID: 2224694
[TBL] [Abstract][Full Text] [Related]
13. Early versus deferred zidovudine monotherapy: impact on AIDS-free time and survival in the multicenter AIDS cohort study.
Detels R; Muñoz A; Peng Y; Graham N; Mellors J; Phair J
Antivir Ther; 1997 Jan; 2(1):21-9. PubMed ID: 11322263
[TBL] [Abstract][Full Text] [Related]
14. [Problems posed by therapeutic combinations of zidovudine during the treatment of opportunistic infections in AIDS].
Meyohas MC; Eliaszewicz M; Stromboni C; Frottier J
Therapie; 1989; 44(6):409-11. PubMed ID: 2623655
[TBL] [Abstract][Full Text] [Related]
15. AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine analogue.
Mathé G; Pontiggia P; Orbach-Arbouys S; Triana K; Ambetima N; Morette C; Hallard M; Blanquet D
Biomed Pharmacother; 1996; 50(5):220-7. PubMed ID: 8949403
[TBL] [Abstract][Full Text] [Related]
16. Zidovudine therapy, CD4+ and CD8+ counts are associated with a longer survival following AIDS onset.
Fiala M; Swartz J; Teklehaimanot S; Kermani V; Funnye AS; Sayre JW; Gornbein JA
Lymphology; 1997 Sep; 30(3):128-36. PubMed ID: 9313205
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
[TBL] [Abstract][Full Text] [Related]
18. [Zidovudine. The current status of its evaluation].
Kouzan S; Nebout T
Therapie; 1989; 44(6):393-9. PubMed ID: 2696136
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the pharmacovigilance follow-up of zidovudine].
Gimenez S; Bagheri H; Marchou B; Massip P; Lafont J; Sorbette F; Armengaud M; Montastruc JL
Therapie; 1990; 45(5):407-9. PubMed ID: 2260033
[TBL] [Abstract][Full Text] [Related]
20. Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea program.
Creagh-Kirk T; Doi P; Andrews E; Nusinoff-Lehrman S; Tilson H; Hoth D; Barry DW
JAMA; 1988 Nov; 260(20):3009-15. PubMed ID: 3263514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
